Dow Up0.51% Nasdaq Up0.24%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.43 Up 0.02(1.42%) Nov 21, 4:00PM EST
|After Hours : 1.43 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 30, 2014Apr 30, 2013Apr 30, 2012
Total Revenue 22,401   21,683   15,233  
Cost of Revenue13,110  12,595  10,153  
Gross Profit 9,291   9,088   5,080  
Operating Expenses
Research Development27,723  24,306  35,688  
Selling General and Administrative17,274  13,134  11,462  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (35,706) (28,352) (42,070)
Income from Continuing Operations
Total Other Income/Expenses Net349  (1,374)41  
Earnings Before Interest And Taxes(35,357)(28,030)(42,029)
Interest Expense5  54  90  
Income Before Tax(35,362)(28,084)(42,119)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(35,362)(29,780)(42,119)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (35,362) (29,780) (42,119)
Preferred Stock And Other Adjustments(401) -   -  
Net Income Applicable To Common Shares (35,763) (29,780) (42,119)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.